2,4-thiazolidinedione has been researched along with Diabetes Mellitus, Lipoatrophic in 1 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Diabetes Mellitus, Lipoatrophic: A type of diabetes mellitus that is characterized by severe INSULIN RESISTANCE and LIPODYSTROPHY. The latter may be generalized, partial, acquired, or congenital (LIPODYSTROPHY, CONGENITAL GENERALIZED).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rosiglitazone treatment increased the triglyceride content of the steatotic livers of A-ZIP/F-1 and ob/ob mice, but not the "lean" livers of fat-transplanted A-ZIP/F-1 mice." | 1.31 | Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. ( Arioglu, E; Chao, L; Gavrilova, O; Marcus-Samuels, B; Mason, MM; Moitra, J; Reitman, ML; Vinson, C, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, L | 1 |
| Marcus-Samuels, B | 1 |
| Mason, MM | 1 |
| Moitra, J | 1 |
| Vinson, C | 1 |
| Arioglu, E | 1 |
| Gavrilova, O | 1 |
| Reitman, ML | 1 |
1 other study available for 2,4-thiazolidinedione and Diabetes Mellitus, Lipoatrophic
| Article | Year |
|---|---|
Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones.
Topics: Adipose Tissue; Animals; Blood Glucose; Chromans; Diabetes Mellitus, Lipoatrophic; Disease Models, A | 2000 |